Fusion Antibodies PLC (FAB) — Cash Flow Quality Index

Latest as of June 2017: -0.31x

Fusion Antibodies PLC (FAB) has a Cash Flow Quality Index of -0.31x as of June 2017. Operating cash flow of GBX-9.34K is below net income of GBX29.99K, suggesting accrual-heavy earnings not yet converted to cash. Explore cash efficiency ratio of Fusion Antibodies PLC to assess how effectively this company generates cash.

Cash Flow Quality Index

-0.31x
Operating CF / Net Income

Operating Cash Flow

GBX-9.34K
GBX

Net Income

GBX29.99K
GBX

Data as of

Jun 2017
Most recent filing

Fusion Antibodies PLC Cash Flow Quality Index (2016–2017)

Historical Cash Flow Quality Index for Fusion Antibodies PLC across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check FAB cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Cash Flow Quality Index for Fusion Antibodies PLC (2016–2017)

Year-by-year earnings quality comparison for Fusion Antibodies PLC. For live market cap and the full company financial profile, see market value of Fusion Antibodies PLC.

Year Quality Index Operating CF (GBX) Net Income YoY Change
2017 -0.31x GBX-37.37K GBX119.95K ▼ -203.8%
2016 0.30x GBX346.57K GBX1.15 Million
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.